The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Left ventricular ejection fraction (LVEF) monitoring in breast cancer patients treated by trastuzumab: A 7-year retrospective study confirms interest of testing.
Jean-Baptiste Rey
No relevant relationships to disclose
Soizic Masson
No relevant relationships to disclose
Laurent Masson
No relevant relationships to disclose
Helene Larbre
No relevant relationships to disclose
Dimitri Papathanassiou
No relevant relationships to disclose